Russian pharma giant to invest in Turkey
R-Pharm, one of Russia’s leading pharmaceutical producers is planning to invest up to €100 million in a subsidiary in Turkey, initially for marketing and promotion of its products with manufacturing to be added at a later stage, media reported. With a recently opened office in Istanbul, R-Pharm intends to invest in biotechnology manufacturing in Turkey, according to its CEO Vasily Ignatiev, who said that the company was aiming to export its products to the Middle Eastern and African markets from Turkey, taking advantage of the country’s strategic location. Turkey has the 14th largest pharmaceuticals market in the world and 6th largest in Europe.
ADVERTISEMENT
MNB Sees Broadening Disinflationary Impact Till Year-end
Viktor Orbán Meets Marine Le Pen
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
